Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 92,145 |
|
|||||
| News | - | ||||||
| Day High | 43.875 | Low High |
|||||
| Day Low | 40.5101 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings Inc | CRBP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.75 | -1.71% | 42.99 | 19:41:39 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 43.65 | 40.5101 | 43.875 | 42.99 | 43.74 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,889 | 92,145 | $ 42.58 | $ 3,923,885 | - | 3.0334 - 49.8699 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:47:37 | 1 | $ 42.01 | USD |
Corbus Pharmaceuticals Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 450.15M | 10.49M | - | 0 | -44.6M | -4.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Corbus Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRBP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 38.79 | 44.66 | 37.41 | 42.16 | 366,492 | 4.20 | 10.83% |
| 1 Month | 39.65 | 45.00 | 32.0288 | 39.66 | 265,341 | 3.34 | 8.42% |
| 3 Months | 22.31 | 49.8699 | 21.965 | 37.87 | 301,166 | 20.68 | 92.69% |
| 6 Months | 3.31 | 49.8699 | 3.0334 | 30.10 | 527,938 | 39.68 | 1,198.79% |
| 1 Year | 9.79 | 49.8699 | 3.0334 | 29.42 | 270,203 | 33.20 | 339.12% |
| 3 Years | 48.69 | 68.70 | 2.11 | 19.16 | 1,278,081 | -5.70 | -11.71% |
| 5 Years | 211.50 | 322.50 | 2.11 | 64.33 | 2,190,422 | -168.51 | -79.67% |
Corbus Pharmaceuticals Description
| Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune system. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. |
